Abstract
Summary
LPI (LP Information)' newest research report, the “Telmisartan Industry Forecast” looks at past sales and reviews total world Telmisartan sales in 2022, providing a comprehensive analysis by region and market sector of projected Telmisartan sales for 2023 through 2029. With Telmisartan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Telmisartan industry.
This Insight Report provides a comprehensive analysis of the global Telmisartan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Telmisartan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Telmisartan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Telmisartan and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Telmisartan.
The global Telmisartan market size is projected to grow from US$ 3178.1 million in 2022 to US$ 4050.8 million in 2029; it is expected to grow at a CAGR of 4050.8 from 2023 to 2029.
United States market for Telmisartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Telmisartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Telmisartan is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Telmisartan players cover Pfizer, Teva, Boehringer Ingelheim, Novartis, Mylan, Reddy's Laboratories (UK), Hema Pharmaceuticals Pvt, Bayer and GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Telmisartan market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Injection
Freeze-Dried Powder
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Telmisartan market?
What factors are driving Telmisartan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Telmisartan market opportunities vary by end market size?
How does Telmisartan break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Telmisartan Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Telmisartan by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Telmisartan by Country/Region, 2018, 2022 & 2029
2.2 Telmisartan Segment by Type
2.2.1 Injection
2.2.2 Freeze-Dried Powder
2.3 Telmisartan Sales by Type
2.3.1 Global Telmisartan Sales Market Share by Type (2018-2023)
2.3.2 Global Telmisartan Revenue and Market Share by Type (2018-2023)
2.3.3 Global Telmisartan Sale Price by Type (2018-2023)
2.4 Telmisartan Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Telmisartan Sales by Application
2.5.1 Global Telmisartan Sale Market Share by Application (2018-2023)
2.5.2 Global Telmisartan Revenue and Market Share by Application (2018-2023)
2.5.3 Global Telmisartan Sale Price by Application (2018-2023)
3 Global Telmisartan by Company
3.1 Global Telmisartan Breakdown Data by Company
3.1.1 Global Telmisartan Annual Sales by Company (2018-2023)
3.1.2 Global Telmisartan Sales Market Share by Company (2018-2023)
3.2 Global Telmisartan Annual Revenue by Company (2018-2023)
3.2.1 Global Telmisartan Revenue by Company (2018-2023)
3.2.2 Global Telmisartan Revenue Market Share by Company (2018-2023)
3.3 Global Telmisartan Sale Price by Company
3.4 Key Manufacturers Telmisartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Telmisartan Product Location Distribution
3.4.2 Players Telmisartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Telmisartan by Geographic Region
4.1 World Historic Telmisartan Market Size by Geographic Region (2018-2023)
4.1.1 Global Telmisartan Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Telmisartan Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Telmisartan Market Size by Country/Region (2018-2023)
4.2.1 Global Telmisartan Annual Sales by Country/Region (2018-2023)
4.2.2 Global Telmisartan Annual Revenue by Country/Region (2018-2023)
4.3 Americas Telmisartan Sales Growth
4.4 APAC Telmisartan Sales Growth
4.5 Europe Telmisartan Sales Growth
4.6 Middle East & Africa Telmisartan Sales Growth
5 Americas
5.1 Americas Telmisartan Sales by Country
5.1.1 Americas Telmisartan Sales by Country (2018-2023)
5.1.2 Americas Telmisartan Revenue by Country (2018-2023)
5.2 Americas Telmisartan Sales by Type
5.3 Americas Telmisartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Telmisartan Sales by Region
6.1.1 APAC Telmisartan Sales by Region (2018-2023)
6.1.2 APAC Telmisartan Revenue by Region (2018-2023)
6.2 APAC Telmisartan Sales by Type
6.3 APAC Telmisartan Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Telmisartan by Country
7.1.1 Europe Telmisartan Sales by Country (2018-2023)
7.1.2 Europe Telmisartan Revenue by Country (2018-2023)
7.2 Europe Telmisartan Sales by Type
7.3 Europe Telmisartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Telmisartan by Country
8.1.1 Middle East & Africa Telmisartan Sales by Country (2018-2023)
8.1.2 Middle East & Africa Telmisartan Revenue by Country (2018-2023)
8.2 Middle East & Africa Telmisartan Sales by Type
8.3 Middle East & Africa Telmisartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Telmisartan
10.3 Manufacturing Process Analysis of Telmisartan
10.4 Industry Chain Structure of Telmisartan
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Telmisartan Distributors
11.3 Telmisartan Customer
12 World Forecast Review for Telmisartan by Geographic Region
12.1 Global Telmisartan Market Size Forecast by Region
12.1.1 Global Telmisartan Forecast by Region (2024-2029)
12.1.2 Global Telmisartan Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Telmisartan Forecast by Type
12.7 Global Telmisartan Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Telmisartan Product Portfolios and Specifications
13.1.3 Pfizer Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Telmisartan Product Portfolios and Specifications
13.2.3 Teva Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Telmisartan Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Telmisartan Product Portfolios and Specifications
13.4.3 Novartis Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Telmisartan Product Portfolios and Specifications
13.5.3 Mylan Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Reddy's Laboratories (UK)
13.6.1 Reddy's Laboratories (UK) Company Information
13.6.2 Reddy's Laboratories (UK) Telmisartan Product Portfolios and Specifications
13.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Reddy's Laboratories (UK) Main Business Overview
13.6.5 Reddy's Laboratories (UK) Latest Developments
13.7 Hema Pharmaceuticals Pvt
13.7.1 Hema Pharmaceuticals Pvt Company Information
13.7.2 Hema Pharmaceuticals Pvt Telmisartan Product Portfolios and Specifications
13.7.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hema Pharmaceuticals Pvt Main Business Overview
13.7.5 Hema Pharmaceuticals Pvt Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Telmisartan Product Portfolios and Specifications
13.8.3 Bayer Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Telmisartan Product Portfolios and Specifications
13.9.3 GSK Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Astellas Pharma Inc
13.10.1 Astellas Pharma Inc Company Information
13.10.2 Astellas Pharma Inc Telmisartan Product Portfolios and Specifications
13.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Astellas Pharma Inc Main Business Overview
13.10.5 Astellas Pharma Inc Latest Developments
13.11 Nippon Boehringer Ingelheim
13.11.1 Nippon Boehringer Ingelheim Company Information
13.11.2 Nippon Boehringer Ingelheim Telmisartan Product Portfolios and Specifications
13.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Nippon Boehringer Ingelheim Main Business Overview
13.11.5 Nippon Boehringer Ingelheim Latest Developments
13.12 Abbott
13.12.1 Abbott Company Information
13.12.2 Abbott Telmisartan Product Portfolios and Specifications
13.12.3 Abbott Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Abbott Main Business Overview
13.12.5 Abbott Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Telmisartan Product Portfolios and Specifications
13.13.3 Takeda Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Beijing Wansheng Pharmaceutical
13.14.1 Beijing Wansheng Pharmaceutical Company Information
13.14.2 Beijing Wansheng Pharmaceutical Telmisartan Product Portfolios and Specifications
13.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Beijing Wansheng Pharmaceutical Main Business Overview
13.14.5 Beijing Wansheng Pharmaceutical Latest Developments
14 Research Findings and Conclusion